We are a leading provider of services in pharmacoepidemiology and therapeutic risk management. Our broad expertise enables you to understand the effects of your product in pre-approval phases as well as in real-life populations. Our academic profile and regulatory expertise serve to optimize your risk management plan and your product’s formulary listing.
 |
| YolaRx is expanding its services: Now offering capacities in data management, through a strategic partnership with Dacima Software Inc. This enables us to conduct multi-center effectiveness and safety studies. |
Yola Moride, President of YOLARx, became President of the International Society for Pharmacoepidemiology (ISPE) at the annual conference in Quebec City (August 19-22)
We have created and evaluated disease management programs to improve drug adherence.
| Persistance.ca |